Published :
Tables : 48
Figures : 43
Category : Healthcare
No. of Pages : 224
Report Code : HC-U9949
Paget's Disease Treatment Market Overview: Paget disease can be defined as a condition that affects the normal function of bone remodeling by removing bone material. There are no symptoms for Paget disease and many people who suffer from it don't know what to do. The treatment of Paget disease involves the removal of affected bones, legs, and pelvis. A chronic bone disorder called Osteitis, also known as Paget's disease or Osteitis, can affect one bone (monostotic), or multiple bones (polyostotic). This causes an abnormally long, weak, and brittle bone structure. The main causes of this disease are disordered bone production and excessive bone breaking down. This can lead to pain and fractures around the affected bones. Paget's disease causes bone remolding to be disrupted, which can lead to thick and brittle bones. The most commonly affected bones are the femur and pelvis, spine, and tibia. The majority of Paget's patients are not affected by symptoms. However, some sufferers may experience bone pain, secondary osteoarthritis, and bone deformities. This is the second most common bone remodeling disorder after osteoporosis. It affects mainly white older adults over 55 years. This disease is more common in the United Kingdom and Northern Europe than in any other race. It is rare to be reported in Asia or Africa. The market will grow if there is an increase in government awareness about the disease. Also, the rise in disease prevalence, rising healthcare costs in the US, and a rise in knowledge and awareness are key factors driving Paget's disease treatment market expansion. In the 2021-2028 forecast period, the market for Paget's disease treatment will see a rise in research and development and higher demand from emerging countries. The market will see new opportunities during the forecast period due to rising biotechnology research expenditures, increased demand from emerging countries, and an increase in research & development activities in the developed countries on Paget's disease treatment options. FutureWise Market Research has instantiated a report that provides an intricate analysis of Paget's Disease Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Paget's Disease Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Paget's Disease Treatment Market: • Novartis AG • Teva Pharmaceutical Industries Ltd • Mylan NV • Neopharma Inc • Allergan • Sanofi S.A. • Fresenius Kabi • mallinckrodt Pharmaceuticals • Sun Pharmaceutical • Merck KGaA (Note: The list of the major players will be updated with the latest market scenario and trends) Paget's Disease Treatment Market Segmentation: By Type • Bisphosphonates • Calcitonin Analogues • Analgesics • Vitamin D Supplements By Route of Administration • Oral • Intravenous • Topical By End User • Hospitals • Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Paget's Disease Treatment Market By Type, By Route of Administration, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Paget disease can be defined as a condition that affects the normal function of bone remodeling by removing bone material. There are no symptoms for Paget disease and many people who suffer from it don't know what to do. The treatment of Paget disease involves the removal of affected bones, legs, and pelvis. A chronic bone disorder called Osteitis, also known as Paget's disease or Osteitis, can affect one bone (monostotic), or multiple bones (polyostotic). This causes an abnormally long, weak, and brittle bone structure. The main causes of this disease are disordered bone production and excessive bone breaking down. This can lead to pain and fractures around the affected bones. Paget's disease causes bone remolding to be disrupted, which can lead to thick and brittle bones. The most commonly affected bones are the femur and pelvis, spine, and tibia. The majority of Paget's patients are not affected by symptoms. However, some sufferers may experience bone pain, secondary osteoarthritis, and bone deformities. This is the second most common bone remodeling disorder after osteoporosis. It affects mainly white older adults over 55 years. This disease is more common in the United Kingdom and Northern Europe than in any other race. It is rare to be reported in Asia or Africa. The market will grow if there is an increase in government awareness about the disease. Also, the rise in disease prevalence, rising healthcare costs in the US, and a rise in knowledge and awareness are key factors driving Paget's disease treatment market expansion. In the 2021-2028 forecast period, the market for Paget's disease treatment will see a rise in research and development and higher demand from emerging countries. The market will see new opportunities during the forecast period due to rising biotechnology research expenditures, increased demand from emerging countries, and an increase in research & development activities in the developed countries on Paget's disease treatment options. FutureWise Market Research has instantiated a report that provides an intricate analysis of Paget's Disease Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Paget's Disease Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Paget's Disease Treatment Market: • Novartis AG • Teva Pharmaceutical Industries Ltd • Mylan NV • Neopharma Inc • Allergan • Sanofi S.A. • Fresenius Kabi • mallinckrodt Pharmaceuticals • Sun Pharmaceutical • Merck KGaA (Note: The list of the major players will be updated with the latest market scenario and trends) Paget's Disease Treatment Market Segmentation: By Type • Bisphosphonates • Calcitonin Analogues • Analgesics • Vitamin D Supplements By Route of Administration • Oral • Intravenous • Topical By End User • Hospitals • Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Paget's Disease Treatment Market By Type, By Route of Administration, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Paget's Disease Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Paget's Disease Treatment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Paget's Disease Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Paget's Disease Treatment Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Bisphosphonates 7.2. Calcitonin Analogues 7.3. Analgesics 7.4. Vitamin D Supplements 8. Paget's Disease Treatment Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Oral 8.2. Intravenous 8.3. Topical 9. Paget's Disease Treatment Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Clinics 9.3. Others 10. North America Paget's Disease Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Paget's Disease Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Paget's Disease Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Paget's Disease Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Novartis AG 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Teva Pharmaceutical Industries Ltd 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Mylan NV 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Neopharma Inc 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Allergan 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Sanofi S.A. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Fresenius Kabi 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. mallinckrodt Pharmaceuticals 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Sun Pharmaceutical 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Merck KGaA 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics